Sasha Damouni Ellis | Vice President-Corporate Affairs and Investor Relations |
Scott Braunstein | Chief Executive Officer |
Christy Shafer | Chief Commercial Officer |
Joe Hulihan | Chief Medical Officer |
Steve Pfanstiel | Chief Financial Officer |
Joseph Thome | Cowen and Company |
Andrew Tsai | Jefferies |
Douglas Tsao | H.C. Wainwright |
Jay Olson | Oppenheimer |
Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals’ Third Quarter 2022 Financial Results and Business Update Call. [Operator Instructions] And now it's my pleasure to introduce your host, Sasha Damouni Ellis, Vice President of Corporate Affairs and Investor Relations.
You may begin Ms. Damouni Ellis.
Thank you and good morning.